Avant Diagnostics Inc (AVDX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Employees:
217 PERRY PARKWAY, SUITE 8, GAITHERSBURG, MD 20877
(732) 410-9810

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 6.892 Million Shares Outstanding215.36 Million Avg 30-day Volume 38.743 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.01
Price to Revenue0.0 Debt to Equity0.03 EBITDA-2.323 Million
Price to Book Value3.2799 Operating Margin0.0 Enterprise Value6.087 Million
Current Ratio0.021 EPS Growth0 Quick Ratio0.021
1 Yr BETA -2.0935 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth-2144.4552 Altman Z-Score-10.783 Free Cash Flow to Firm -2.482 Million

Are you looking for this stock instead?

View SEC Filings from AVDX instead.

View recent insider trading info

Avant Diagnostics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AVDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVDX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2021-10-12 by HARRIS MATTHEW C
  • 3: filed on 2021-10-12 by SALEM ENRIQUE T
  • 3: filed on 2021-10-12 by DREES DANIEL
  • 3: filed on 2021-10-12 by PRAEGER MICHAEL
  • 3: filed on 2021-10-12 by STAHL RYAN
  • 3: filed on 2021-10-12 by HAUSMAN JAMES E
  • 3: filed on 2021-10-12 by WILHITE JOEL
  • 3: filed on 2021-10-12 by MURDOCK WENDY J.
  • 3: filed on 2021-10-12 by Cunningham Todd Alan
  • 3: filed on 2021-10-12 by MORRIS NIGEL W

    • Events (8k)

  • 8-K: filed on 2019-04-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
  • 8-K: filed on 2018-05-25:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-04-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-12-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2017-11-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2017-11-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2017-09-28:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-09-26:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-08-31:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HAUSMAN JAMES E

    • Director
    		 819,784 2021-10-12 1

    MORRIS NIGEL W

    • Director
    		 0 2021-10-12 1

    BAIN CAPITAL VENTURE INVESTORS, LLC

    BAIN CAPITAL VENTURE COINVESTMENT FUND, L.P.

    BAIN CAPITAL VENTURE COINVESTMENT PARTNERS, L.P.

    BAIN CAPITAL VENTURE FUND 2014, L.P.

    BAIN CAPITAL VENTURE PARTNERS 2014, L.P.

    BCV AX INVESTORS, L.P.

    BCIP VENTURE ASSOCIATES

    BCIP VENTURE ASSOCIATES-B

    SALEM ENRIQUE T

    AGARWAL AJAY

    • 10% Owner
    		 0 2021-10-12 1

    MORRIS JOHN C.

    • Director
    		 0 2021-10-12 1

    HARRIS MATTHEW C

    • Director
    • 10% Owner
    		 0 2021-10-12 1

    DRUMMOND LANCE F.

    • Director
    		 0 2021-10-12 1

    MURDOCK WENDY J.

    • Director
    		 0 2021-10-12 1

    MCGUIRE JAMES MICHAEL

    • Director
    		 0 2021-10-12 1

    PRAEGER MICHAEL SEE REMARKS

    • Officer
    • Director
    		 11,505,348 2021-10-12 1

    STAHL RYAN SEE REMARKS

    • Officer
    		 96,008 2021-10-12 1

    GIBSON ANGELIC SEE REMARKS

    • Officer
    		 0 2021-10-12 1

    MACKINTOSH TERESA

    • Director
    		 0 2021-10-12 1

    DREES DANIEL SEE REMARKS

    • Officer
    		 92,265 2021-10-12 1

    CUNNINGHAM TODD ALAN SEE REMARKS

    • Officer
    		 0 2021-10-12 1

    WILHITE JOEL SEE REMARKS

    • Officer
    		 0 2021-10-12 1

    SHROTRIYA RAJESH C MD

    • Director
    		 0 2018-08-28 0

    DELAO ANDREW JOHN

    • Director
    		 0 2018-08-28 0

    RUXIN MICHAEL I CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2018-08-23 0

    BUSCH JEFFREY

    • Director
    		 0 2018-08-20 0

    COLE HENRY

    • Director
    		 0 2018-06-09 0

    BRUGMANN JOHN EDWARD

    • Director
    		 0 2018-05-25 0

    TRAPP ROBERT H

    • Director
    		 0 2017-11-07 0

    INFUSION 51A, L.P.

    STEPHENS JEFFREY

    VANDERMEER SCOTT

    • Director
    • 10% Owner
    		 11,283,333 2017-08-09 0

    INFUSION 51A, L.P.

    • 10% Owner
    		 13,283,333 2017-06-19 0

    STEPHENS JEFFREY

    • Director
    • 10% Owner
    		 17,358,333 2017-06-19 0

    VANDERMEER SCOTT

    • 10% Owner
    		 17,358,333 2017-06-19 0

    SCOTT STEVEN EUGENE

    • 10% Owner
    		 15,241,176 2015-04-10 0

    PLUMB STEVEN M CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    • 10% Owner
    		 34,000,000 2014-12-29 0

    DELTA S VENTURES, LP CHAIRMAN

    • Officer
    • Director
    • 10% Owner
    		 34,000,000 2014-12-29 0

    VOLLMERS ALVARO SEE REMARKS

    • Officer
    • Director
    • 10% Owner
    		 150,000 2010-05-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 15:15:03 UTC -0.18 0.25 3000
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 14:45:02 UTC -0.18 0.25 20000
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 14:15:03 UTC -0.18 0.25 20000
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 13:45:03 UTC -0.18 0.25 20000
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 13:15:03 UTC -0.18 0.25 20000
    AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 12:45:03 UTC -0.18 0.25 20000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments